BM Hylunidase 1500IU – Hyaluronidase Injection for Dermal Filler Dissolution & Aesthetic Correction

BM Hylunidase 1500IU is a professional hyaluronidase injection formulated to dissolve hyaluronic acid-based dermal fillers and support aesthetic correction procedures. Containing 1,500 IU of hyaluronidase per vial, this enzyme-based solution is widely used by aesthetic practitioners to address filler overcorrection, asymmetry, unwanted filler results, and certain filler-related complications. BM Hylunidase may also be utilized to enhance tissue permeability and support the dispersion of injectable solutions during professional aesthetic treatments.

Key Benefits

• Contains 1,500 IU of Hyaluronidase per vial
• Helps dissolve hyaluronic acid dermal fillers
• Supports correction of overfilled treatment areas
• Assists in managing uneven filler distribution
• Promotes improved tissue permeability
• May enhance dispersion of injectable solutions
• Supports aesthetic correction procedures
• Fast-acting enzymatic activity
• Widely used in professional aesthetic medicine

Common Applications

• Dissolving hyaluronic acid fillers
• Correction of filler overcorrection
• Management of uneven filler placement
• Aesthetic revision procedures
• Supportive treatment for filler-related complications
• Tissue permeability enhancement
• Adjunctive use in fat-dissolving protocols
• Promotion of fluid reabsorption in tissues

Product Specifications

• Product Name: BM Hylunidase 1500IU
• Type: Hyaluronidase Injection
• Active Ingredient: Hyaluronidase 1,500 IU
• Form: Lyophilized Powder for Injection
• Packaging: 10 Vials per Box
• Category: Filler Dissolving Enzyme
• Origin: South Korea
• Usage: Professional use only

Active Ingredient

• Hyaluronidase 1,500 IU per vial

Technology & Mechanism

Hyaluronic Acid Degradation

BM Hylunidase contains hyaluronidase, an enzyme that breaks down hyaluronic acid molecules. When administered by qualified professionals, it helps dissolve hyaluronic acid-based dermal fillers, allowing the treated material to be naturally metabolized and eliminated by the body.

Filler Correction Support

The product is commonly used to correct overfilled areas, asymmetry, misplaced filler, and undesirable aesthetic outcomes resulting from hyaluronic acid filler treatments.

Enhanced Tissue Permeability

Hyaluronidase temporarily increases tissue permeability, helping improve the dispersion and absorption of injected fluids, anesthetics, and other injectable solutions.

Rapid Enzymatic Activity

Following administration, hyaluronidase begins breaking down hyaluronic acid relatively quickly, with visible correction often becoming apparent within several days depending on the amount and location of filler treated.

Treatment Areas

• Lips
• Cheeks
• Chin
• Jawline
• Nose
• Tear trough area
• Temple area
• Other areas treated with hyaluronic acid fillers

Expected Results

• Reduction of unwanted filler volume
• Improved facial symmetry
• Correction of overfilled areas
• Enhanced aesthetic outcomes
• Improved filler distribution appearance
• Support for revision procedures

Results vary based on filler type, injection depth, treatment area, and individual patient characteristics. Multiple sessions may be required in some cases.

Typical Treatment Protocol

• Assessment of filler placement and volume
• Reconstitution before administration
• Targeted injection into treatment area
• Follow-up evaluation after treatment
• Additional sessions if clinically indicated

Treatment protocols should always be determined by qualified healthcare professionals.

Administration

BM Hylunidase is intended for professional use and may be administered for:

• Dermal filler dissolution procedures
• Aesthetic correction treatments
• Management of filler-related complications
• Enhancement of tissue permeability
• Adjunctive aesthetic treatment protocols

Only licensed healthcare practitioners trained in injectable aesthetic procedures should perform treatment.

Storage Instructions

• Store below 25°C (77°F)
• Protect from direct sunlight
• Keep in original packaging
• Maintain sterile handling conditions
• Use according to manufacturer guidelines

 

Safety Information

Temporary treatment-related effects may include:

• Injection site redness
• Mild swelling
• Tenderness
• Bruising
• Temporary discomfort at treatment sites

As with any injectable treatment, administration should be performed only by qualified professionals following appropriate medical protocols.

Ideal Candidates

BM Hylunidase may be suitable for individuals seeking:

• Correction of hyaluronic acid filler results
• Reduction of overfilled treatment areas
• Improved facial symmetry
• Management of unwanted filler outcomes
• Professional aesthetic revision procedures

Important Notice

BM Hylunidase 1500IU is intended strictly for use by licensed healthcare practitioners trained in aesthetic injectable procedures. The product should only be administered following professional assessment and according to applicable medical guidelines.